ZENSARTECHNSEZensar Technologies Limited· IT - SoftwareHighPositive
Announced Fri, 31 Oct, 2025 · 19:31 IST

Q2FY26 revenue rises 4.2%, EBITDA margin improves to 15.4%

Ebitda Margin ExpansionResults View source PDFExplain this filing

ZENSARTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.1%Reaction day
₹795.45
prior close
₹792.95
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%-5.8% vs market
Computers - Software & Consulting peers, median of 62sector+0.2%-5.4% vs sector

On the reaction day the stock moved 5.8 pts less than Nifty Smallcap 250 and 5.4 pts less than its Computers - Software & Consulting peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-5.0
10m
-4.0
15m
-4.3
30m
-3.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.1+0.7-5.8+0.2-5.4
Next day
-7.5+0.0-7.5-0.9-6.6
2d
-12.0-1.5-10.5-1.1-10.9
3d
-11.9-1.7-10.2-1.9-10.0
4d
-8.9-1.7-7.1-1.7-7.1
5d
-8.2-1.8-6.4-0.6-7.6
1w
-8.5-1.5-7.0+1.2-9.7
15d
-9.6-3.9-5.7-4.7-4.9
1m
-7.2-4.0-3.2-3.7-3.5
2m
-10.8-2.7-8.1-5.0-5.8
3m
-15.5-7.8-7.7-13.4-2.1
UpDownMarket · Nifty Smallcap 250Sector · Computers - Software & Consulting peers, median of 62Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zensar reported Q2FY26 revenue of $162.8 million, up 4.2% year on year and 0.5% sequentially. EBITDA was $25.1 million, with margin improving to 15.4% from 15.2% in Q1. PAT was $20.8 million, up 11.9% year on year but down 2.0% sequentially. The order book was $158.7 million, while TMT revenue fell 6.7% year on year.

Likely market impact

Moderate growth and stable profitability are supportive, but the sequential PAT decline and weak TMT business may limit near-term investor enthusiasm.